Home › Funds › Artia Global Partners LP › TVTX

Artia Global Partners LP position in TVTX

TRAVERE THERAPEUTICS INC · Health Care

Artia Global Partners LP reported holding 398,493 shares of TVTX (TRAVERE THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$23.5M, representing 4.73% of its reported portfolio and ranking #7 among its reported holdings. Artia Global Partners LP has disclosed TVTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)398.49K sh
Reported value held$23.46M
Portfolio Weight4.73%
First reportedQ1 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's TVTX position evolved

Artia Global Partners LP first disclosed a stake in TVTX in Q1 2025 at 30,900 shares (US$554K). The position peaked in Q3 2026 at 398,493 shares, worth US$23.5M. Across 7 filings, Artia Global Partners LP increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 398,493 shares valued at US$23.5M — an increase of 59,460 shares quarter over quarter.. Notable position changes include a 129% increase in Q4 2025 (shares fell 22% over the following quarter), a 380% increase in Q2 2026 (shares rose 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 30.90K $553.73K New
Q2 2025 30.90K $457.32K Hold
Q3 2025 30.90K $738.51K Hold
Q4 2025 70.70K $2.70M Add
Q1 2026 70.70K $2.10M Hold
Q2 2026 339.03K $19.26M Add
Q3 2026 398.49K $23.46M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TVTX and 13F data

TVTX (TRAVERE THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in TVTX — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$213.2M), Rock Springs Capital Management LP (US$129.8M), Kynam Capital Management, LP (US$117.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TVTX

All TVTX fund holders →

FAQ

How long has Artia Global Partners LP held TVTX?

Artia Global Partners LP has disclosed TVTX holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Artia Global Partners LP's current position in TVTX?

As of Q3 2026, Artia Global Partners LP holds 398.49K shares of TVTX (TRAVERE THERAPEUTICS INC), valued at $23.46M, representing 4.73% of its reported portfolio and ranking #7.

Has Artia Global Partners LP been buying or selling TVTX?

In the latest 13F filing (Q3 2026), Artia Global Partners LP increased its position in TVTX. The position peaked in Q3 2026 at 398.49K shares.

Which other funds hold TVTX?

Other major institutional holders of TVTX include PERCEPTIVE ADVISORS LLC, Rock Springs Capital Management LP, Kynam Capital Management, LP, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.